RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice
Fabrizio Pin(Indiana University Health), Andrea Bonetto(University of Miami)
Cited by 36
Related Papers
STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
|PLoS ONE|2011|347
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
|Oncotarget|2016|196
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
|Journal of Cachexia Sarcopenia and Muscle|2018|98
HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
|Disease Models & Mechanisms|2020|47
The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
|Frontiers in Cell and Developmental Biology|2022|44